Ammunition Life-tech Leads with Sixth NMPA-Approved Methylation Kit as China's Total Reaches 44
Ammunition
Early Non-Invasive Testing Product Developer
ORIOMICS
Early Screening Product Developer for Digestive System Tumors
Ningbo Aikelun
Medical Device Manufacturer
According to the latest news, Ammunition has newly obtained a methylation kit for urothelial carcinoma, featuring two genes: VIM and a newly discovered, yet unnamed gene, AL021918.2.ORIOMICSNewly Obtained 6-Gene Liver Cancer Methylation Kit.
As of now, there are 12 newly approved methylation tests in China for 2025.
A total of 44 certificates, involving 30 companies.
Wuhan Ammunition Life-tech Co., Ltd. has obtained 5 certifications, adding Kapok's cervical cancer certification, totaling 6, far ahead!
Ningbo Aikelun, Biochain, and Anhui Targene Medical Technology Co., Ltd. followed closely with three certifications.
43 certificates are related to tumors.
The other one is systemic lupus erythematosus.
Colorectal cancer testing is leading with 17 options, including 7 blood-based tests and 10 stool-based tests.
Next is cervical cancer, 5 cases.
Urothelial Carcinoma and Lung Cancer, 4 slides.
Methylation detection, 1 digital PCR, the rest are Q-PCR
Two kits contain gene mutations.
There is 1 kit containing fecal occult blood.
Charges and Medical Insurance, No Updates This Time
The above data is accurate as of October 31, 2025.